Physician profile
Benetta Duhart
NPI 1740249838
$2,269.73
in general payments reported to CMS, 2019-2025
26 companies · $469 in 2025
The $469 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $193 · 2021: $477 · 2022: $92.25 · 2023: $456 · 2024: $482 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,329 · Education: $78.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,329.07 |
| Education | $78.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $350.27 | 2021-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $297.57 | 2019-2025 | Liletta |
| Daiichi Sankyo INC. | $277.80 | 2021 | |
| Organon LLC | $181.15 | 2023-2025 | Nexplanon |
| Biogen, INC. | $156.01 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $147.81 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Sumitomo Pharma America, INC. | $116.16 | 2023-2025 | Myfembree |
| Glaxosmithkline, LLC. | $114.84 | 2020 | |
| Mayne Pharma Commercial LLC | $87.01 | 2021-2025 | |
| Pfizer INC. | $74.08 | 2023-2024 | |
| Hologic Sales and Service, LLC | $58.47 | 2023-2024 | Aptima, Acessa Provu System |
| Shield Therapeutics INC | $57.52 | 2023-2024 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $51.26 | 2024-2025 | |
| Aspira Women'S Health INC | $44.25 | 2021-2024 | Ova1 |
| Optumhealth Care Solutions, LLC | $41.82 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spine Wave, INC. | $33.64 | 2019 | |
| Ethicon US, LLC | $28.01 | 2024 | Enseal |
| Lupin INC. | $24.51 | 2019-2020 | |
| Davol INC. | $20.68 | 2025 | Phasix Mesh |
| Smith+Nephew, INC. | $19.97 | 2025 | Pico 14 |
| Allergan, INC. | $17.64 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.80 | 2020 | |
| Mylan Pharmaceuticals INC. | $14.29 | 2021 | |
| Millicent US INC | $13.35 | 2024 | |
| Baxter Healthcare | $13.14 | 2020 | |
| Exeltis, USA INC. | $12.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benetta Duhart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.